Safety End Points

(277) "Take Up to Eight Tablets Per Day": The Impact of Incorporating the Uncertainty of Free-Text Medication Instructions for Drug Exposure Data Preparation

(287) A Replication of the Incidence Rate Estimates of Selected Adverse Events of Special Interest (AESIs) from the vACCine covid-19 monitoring readinESS (ACCESS) in the EU with US Real World Data

(274) A Study of Statins and The Risk of Venous Thromboembolism

(291) Acute Myocardial Infarction, Stroke, and MACE in COPD Patients Treated with Aclidinium and Other Inhaled Bronchodilators

(282) Aromatase Inhibitors and The Incidence of Parkinson's Disease: Population-Based Cohort Study

(283) Association Between Concomitant Use of Direct Oral Anticoagulants and Statins and Major Bleeding in Patients with Non-valvular Atrial Fibrillation

(294) Association Between Initiation of Medical Therapy and Hypo- or Hyperthyroidism - A Population-Based Symmetry Analysis Screening Study

(285) Associations of Thiazide Use with Skin Cancers: A Systematic Review and Meta-Analysis

(292) Atypical Antipsychotic Use and Mortality Risk in Parkinson's Disease

(301) Buprenorphine and Tramadol Prescriptions in Major Depressive Disorder Settings

(288) Cardiovascular Efficacy and Safety of Incretin Mimetics and Sodium-Glucose Co-Transporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs

(271) Comparative Safety of Beta-Blocker and Calcium Channel Blockers in Patients with Chronic Obstructive Pulmonary Disease and Atrial Fibrillation: A National Population Cohort Study in Taiwan

(278) Diabetes Mellitus, Antidiabetic Use and The Risk of Treated Depression in the UK

(272) Differential Risk of Osteoporotic Fractures Associated with Use of Antipsychotics: A Systematic Review and Meta-Analysis

(AG) Mineralocorticoid Receptor Antagonists and Prostate Cancer Risk in Patients with Heart Failure

(AC) A Population Based Assessment of Concomitant Use of Sulfonylureas and Beta-Blockers and The Risk of Severe Hypoglycemia

(267) Effect of Cardiovascular Disease and Diuretic Use on Amputation Risk with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes

(284) Evaluate The Risk of Cardiovascular Event in Rheumatoid Arthritis Patient Receiving Tofacitinib and TNF Inhibitors in Taiwan

(275) Evaluation of a Web-Based Application Monitoring Thiopurine Therapy in The Veterans Health Administration (VHA)

(295) Exposure to Tricyclic and Selective Serotonin Reuptake Inhibitor Antidepressants and The Risk of Hip Fracture: An Updated US-Based Case-Control Study

(297) Flecainide and Risk of Skin Cancer: A Large Population-Based Case-Control Study in Spain and Denmark

(299) Identifying Hospitalizations for Heart Failure in Healthcare Databases: Algorithm Development and Validation

(268) Is Statin Use Associated with An Increased Risk of Adrenal Insufficiency? A Nested Matched Case-Control Study

(281) Leuprolide and Fracture Risk in Patients with Central Precocious Puberty

(265) Long-Term Clinical Outcomes Associated with Antimicrobial Allergies Using Mixed-Effect Survival Models

(293) Opioid-Induced Nausea - A Population-Based Active-Comparator Symmetry Analysis

(300) Peptidomimetic Structure of Dipeptidyl Peptidase-4 Inhibitors and The Risk of Sulfonylurea-Induced Severe Hypoglycemia: A Population-Based Cohort Study

(298) Predicting Individual Risk of Muscle Disorders in Patients Eligible for Statin Treatment: Derivation and External Validation of STRATIFY-StatinMD Prediction Model

(270) Real-World Safety of Factor Xa Inhibitors and Warfarin in Obese and Morbidly Obese Nonvalvular Atrial Fibrillation (NVAF) Patients Using a University Health Center Electronic Medical Record Database in the United States (US)

(286) Risk of Adverse Events Associated with Novel Oral Anticoagulant (Apixaban): A Systematic Review and Meta-Analysis

(296) Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis Treated with Tofacitinib vs Select TNF Inhibitors: Assessing the Concordance of Trial Findings Using Real-World Data

(273) Risk of Clostridium Difficile Infection Associated with Used of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in Taiwan Hospitalized Patients

(290) Risk of Intentional Self Harm and Suicide Among 5-Alpha Reductase Inhibitor Users and Alpha-Blocker Users

(302) Risk of Malignancy in Patients with Rheumatoid Arthritis Treated with Tofacitinib Vs Select TNF Inhibitors: Assessing the Concordance of Trial Findings Using Real-World Data

(269) Risk of Suicidal Behavior Associated with Benzodiazepines: A Nationwide Case-Crossover Study

(266) The Effect of Antibiotics Prescription and Length of Hospitalization on Mortality in Patients with Sepsis

(289) To Use Antipsychotics or Not To Use Antipsychotics? A Population-Based Nested Case-Control Study in Patients with Hospital-Acquired Delirium After Discharge

(279) Use of Oral Contraceptives or Hormone Therapy and Risk of COVID-19 Infection or Hospitalization: A Multisite Cohort Study

(276) Use of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) and Risk of Parkinson's Disease

(280) Warfarin and Sulfonylureas in Individuals with Type 2 Diabetes and Risk of Bleeding: A UK Population-Based Cohort Study